Status:

WITHDRAWN

Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions

Lead Sponsor:

Fundación EPIC

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The DR vs DK trial is designed to elucidate the benefits of Double Rewire crush technique (DR-Crush) over Double Kissing Crush (DK-Crush) technique in patients with Unprotected Left Main Bifurcation l...

Detailed Description

DR vs DK is a multicentre, randomized, prospective, non-inferiority clinical trial designed to evaluate the efficacy and safety of DR crush over DK crush for patients with ULMb. More than 12 tertiary ...

Eligibility Criteria

Inclusion

  • Patients between 18-90 years of age.
  • Patients who gave written informed consent for participation in the trial.
  • Lesions are eligible for percutaneous coronary intervention (PCI).
  • Patient has stable/unstable angina or myocardial infarction (MI): all-comers.
  • ULMb (Medina 1,1,1) with/without left main ostial/shaft lesions. Downstream lesions in LAD or LCX could be covered by two stents. Severe calcification needing rotational atherectomy, orbital atherectomy or Laser are included.
  • Diameter stenosis in LAD/LM and LCX ≥ 50% by visual estimation or minimal luminal area by IVUS in LM ≤6 mm2.

Exclusion

  • Restenotic lesions.
  • Patient was allergic to the study stent or protocol-required concomitant medications.
  • Patient is intolerable to dual anti-platelet therapy.
  • Patient has any other serious medical illness that may reduce life expectancy to \<12 months.
  • Patient is a woman who is pregnant or nursing.
  • Patient has a planned procedure that may cause non-compliance with the protocol or confound data interpretation.
  • Patient is participating in another clinical trial.
  • Patients in shock.

Key Trial Info

Start Date :

February 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05258318

Start Date

February 20 2022

End Date

January 1 2024

Last Update

June 18 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.